Welcome to CaDxPath

We are a translational cancer research group at the Kolling Institute of Medical Research in Sydney, Australia. Our focus is on tissue cancer biomarker discovery and validation.

We work in partnership with oncologists and surgeons on a range of cancer types, employing clinical diagnostic techniques and research methodologies to elucidate aspects of cancer which have potential clinical applications. Our team includes diagnostic pathologists and research scientists with a cumulative experience of well over twenty years in laboratory medicine.

We are a not for profit group supported by the Cancer Institute NSW through its Translational Cancer Research Centre program and Research Infrastructure Grant scheme, with contributing support from the University of Sydney’s Cancer Research Fund and the Pathology North Staff Specialist Trust Fund, Royal North Shore Hospital.

 

Group Leader

PROFESSOR Anthony Gill

Group members

Parafibromin deficient (HPT-JT type,CDC73 mutated) parathyroid tumors.

Succinate dehydrogenase (SDH) deficient renal carcinomas

Follow us on twitter

We are located at Kolling Institute of Medical Research, Sydney, New South Wales, Australia.

Contact Us

© Copyright Cancer Diagnosis And Pathology